Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Total Current Liabilities (2016 - 2025)

Skinvisible (SKVI) has disclosed Total Current Liabilities for 16 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 37.2% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, up 37.2% year-over-year, with the annual reading at $5.0 million for FY2025, 37.2% up from the prior year.
  • Total Current Liabilities hit $5.0 million in Q4 2025 for Skinvisible, up from $4.8 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $5.0 million in Q4 2025 to a low of $2.7 million in Q1 2023.
  • Historically, Total Current Liabilities has averaged $3.7 million across 5 years, with a median of $3.6 million in 2022.
  • Biggest five-year swings in Total Current Liabilities: fell 12.62% in 2023 and later skyrocketed 50.18% in 2024.
  • Year by year, Total Current Liabilities stood at $3.1 million in 2021, then increased by 19.07% to $3.6 million in 2022, then fell by 3.64% to $3.5 million in 2023, then grew by 4.12% to $3.7 million in 2024, then surged by 37.2% to $5.0 million in 2025.
  • Business Quant data shows Total Current Liabilities for SKVI at $5.0 million in Q4 2025, $4.8 million in Q3 2025, and $4.5 million in Q2 2025.